PsychRounds: The Psychiatry Podcast

Today, we have one of the giants and pioneers of Asian-American Psychiatry joining us to discuss Cultural Psychiatry, Dr. Francis Lu! Dr. Lu's Books: https://www.amazon.com/stores/author/B003HFAX8E?ccs_id=d6d03eae-2c95-481f-8f7a-f844580eb108References:https://psychiatryonline.org/doi/10.1176/appi.focus.18103https://psycnet.apa.org/record/2015-37696-000

Welcome back! On todays episode, we will discuss hydroxyzine (Atarax, Vistaril), a frequently used medication for anxiety.References:https://pubmed.ncbi.nlm.nih.gov/9616188/https://pubmed.ncbi.nlm.nih.gov/27998379/https://pubmed.ncbi.nlm.nih.gov/21154375/https://pubmed.ncbi.nlm.nih.gov/1345410/

We're back from our brief hiatus! Today, we are hosting Dr. Matthew Bernstein to talk about a rising subfield of psychiatry - Metabolic Psychiatry. We'll be looking at its history, the ketogenic diet, mitochondria, and more! References- https://pubmed.ncbi.nlm.nih.gov/38273108/- https://pubmed.ncbi.nlm.nih.gov/34113269/- https://pubmed.ncbi.nlm.nih.gov/39296512/- https://pmc.ncbi.nlm.nih.gov/articles/PMC12089804/- https://pubmed.ncbi.nlm.nih.gov/40043464/- https://pubmed.ncbi.nlm.nih.gov/28137247/Metabolic Mind: https://www.metabolicmind.org/Free CME: https://www.mycme.com/courses/ketogenic-therapy-treatment-for-serious-mental-illness-10028Baszucki Group: https://baszuckigroup.com/

Welcome to today's episode on the salience network, the final episode in our three-part series on neural networks. We'll explore how the salience network helps the brain prioritize what matters most by filtering relevant stimuli.References:https://pmc.ncbi.nlm.nih.gov/articles/PMC2899886/https://www.nature.com/articles/s41398-018-0118-6https://www.nature.com/articles/s41598-022-15489-9https://pmc.ncbi.nlm.nih.gov/articles/PMC5913255/

On todays episode we will be discussing Transcranial Magnetic Stimulation with a very special guest, Dr. Jonathan Downar. We will also discuss the ONE-D and THREE-D trails.Three-D Trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30295-2/abstract'One-D Trial: https://www.researchsquare.com/article/rs-5679327/v1SAINT TMS: https://psychiatryonline.org/doi/10.1176/appi.ajp.2019.19070720

On today's episode, we continue our series with a discussion of the Central Executive Network, following our previous episode on the Default Mode Network.References: https://pubmed.ncbi.nlm.nih.gov/30250390/https://pmc.ncbi.nlm.nih.gov/articles/PMC4162869/https://link.springer.com/article/10.3758/s13415-011-0083-5https://www.cell.com/neuron/comments/S0896-6273(06)00349-7https://pubmed.ncbi.nlm.nih.gov/18799601/https://www.nature.com/articles/s41386-021-01132-0

On today's episode we have a special international guest, Dr. Pouya Movahed Rad from Lund University in Sweden. We will be discussing Electroconvulsive therapy (ECT) and the Ket-ECT, and ELEKT-D studies. ELEKTD:https://www.nejm.org/doi/full/10.1056/NEJMoa2302399KET-ECT: https://pubmed.ncbi.nlm.nih.gov/35020871/Comparison: https://pubmed.ncbi.nlm.nih.gov/38114073/

Join us today as we venture into the Triple Network Model as a basis for psychiatric illness, starting with the Default Mode Network. Referenceshttps://pmc.ncbi.nlm.nih.gov/articles/PMC7959111/https://pubmed.ncbi.nlm.nih.gov/37167968/https://www.nature.com/articles/s42003-019-0611-3https://www.psychiatrictimes.com/view/mindwandering-mood-for-thoughthttps://www.nature.com/articles/s41380-021-01403-8https://www.sciencedirect.com/science/article/abs/pii/S0167876022000071https://www.nature.com/articles/tp201740https://pubmed.ncbi.nlm.nih.gov/25938726/

Welcome back! Today we will be discussing Metformin and some of the recent guidelines published in the journal the Schizophrenia Bulletin. (Carolan et. al 2024).

On today's special guest episode, we'll be exploring the topic of nitrous oxide with Dr. Charles Conway and Dr. Vasilis Hristidis.https://medicine.washu.edu/news/laughing-gas-relieves-symptoms-in-people-with-treatment-resistant-depression/https://pmc.ncbi.nlm.nih.gov/articles/PMC5825282/https://pubmed.ncbi.nlm.nih.gov/34108247/https://pubmed.ncbi.nlm.nih.gov/25577164/

In today's episode, we explore ketamine's therapeutic potential with Dr. Joshua Rosenblat, a leading expert and faculty member at the University of Toronto's Department of Psychiatry (learn more). https://x.com/jd_rosenblat?lang=enhttps://pubmed.ncbi.nlm.nih.gov/35688035/https://pubmed.ncbi.nlm.nih.gov/39608193/

Welcome back! Today, we are discussing a new branded medication that combines bupropion with dextromethorphan for the treatment of depression.

Today, we will be discussing tricyclic antidepressants (TCA's). Once again, we've picked a few of our favorites to discuss on today's episode.

Welcome back! Today, we will be discussing MAOIs, and we've picked out a few of our favorites for today's episode.

Could there be an evolutionary perspective for depression? Join us for part two of our series on depression and inflammation.

Join us as we talk about the relationship between depression and inflammation - an interesting biological theory.

Join us as we talk about Loxapine, an older medication that's stood the test of time and found a niche in psychiatric practice.

Welcome back! Today, we have a special guest-episode with a senior medical student, Jun-Hwan Kim. Join us as we talk about anti-psychotic associated weight gain.

Today, we have a very special guest joining us—Dr. John Kane! We will be discussing his experience and history with clozapine, a groundbreaking medication for treatment-resistant schizophrenia.

Join us and we discuss a newer anti-psychotic medication, Lumateperone, brand name Caplyta.

Welcome back to our final partial agonist episode! Today we are discussing Cariprazine, brand name, Vraylar.

Welcome back! Brexpiprazole, also known by its brand name Rexulti, is a relatively new medication. Join us for a brief discussion.

Welcome back! Today we are talking about Aripiprazole, brand name Abilify.

Welcome back and Happy New Year! Today, we are kicking it off with a brief episode on Quetiapine (Seroquel).

Welcome back! Today, we have a short-episode on a unique second generation anti-psychotic, Asenapine (Saphris, Secuado).

Welcome back, on today's episode we will briefly go over the extrapyramidal symptoms associated with anti-psychotics.

Dr. Larry Wang will be hosting todays episode with a very special guest. . . another Dr. Larry Wang? . . . Bipolar depression being treated with an antidepressant? Welcome to the multiverse.

Welcome back to our antipsychotic series. Today, we will be discussing Olanzapine, brand-name, Zyprexa.

Welcome to another special guest episode. In this episode, we are joined by Dr. Christine Yu Moutier, M.D., the acting Chief Medical Officer of the American Foundation for Suicide Prevention. We'll be discussing important topics around suicide prevention and much more. AFSP: ⁠https://afsp.org/⁠ Suicide Prevention Handbook: https://www.cambridge.org/core/books/suicide-prevention/8BE216EF6EF05ABAF83B5C0D7FC9B969

Join us as we take a break from some psychopharmacology. Today, we will be talking about CBT-I, one of the first-line therapy interventions for insomnia.

Welcome back to our sleep series! Today, we're diving into two of the most popular sleep aids: Melatonin and Rozerem.

Join us for our first episode on the orexin antagonists! We will be briefly discussing: Suvorexant, brand-name Belsomra, Lemborexant, brand-name Dayvigo, and Daridorexant, brand-name Quviviq.

In this episode, we explore the Z Drugs—Zolpidem, Zaleplon, and Eszopiclone. Join us as we give a brief introduction to this class of medications commonly used for sleep. ANSWER TO POLL QUESTION BELOW (SPOILER) —————————————————— Answer: Choice B (Zolpidem)

Join us as we discuss a commonly used class of medications for sleep, the H1 antagonists. This includes medications such as hydroxyzine, mirtazapine, doxepin and more Answer to Poll Question Below (SPOILER) —————————————————— Answer: Choice B (Doxepin)

Welcome to our next guest episode! We're excited to have Dr. Barry Krakow, M.D., with us. In this episode, he'll provide an introduction to sleep medicine in psychiatry. Be sure to check out his website below: https://barrykrakowmd.com/ Answer to Poll Question Below (SPOILER) ----------------------------------------------------------------- Answer: E (Priapism)

Did someone say Latuda Lafooda? Join us as we talk about a frequently used anti-psychotic that recently went generic. Answer to Poll Question Below (SPOILER) ----------------------------------------------------------------- Answer: D (CYP 3A4)

On this episode we will be talking about another atypical antipsychotic, Geodon (Ziprasidone). Answer to Poll Question Below (SPOILER) ----------------------------------------------------------------- Answer: C (Akathsia)

Join us as we discuss Invega (Paliperidone) and its various long-acting formulations such as Sustenna, Trinza, and Hafyera.

Join us as we discuss a second generation antipsychotic, Risperidone (Risperdal). We will also cover some the long-acting injectable formulations such as Consta, Uzedy and Perseris. Answer to Poll Question Below (SPOILER) ----------------------------------------------------------------- Answer: D (Low-dose Aripiprazole)

Join us as we discuss another typical antipsychotic, Fluphenazine (Prolixin). Answer to Poll Question Below (SPOILER) ----------------------------------------------------------- Answer: B (1.25)

Today, we will be discussing one of the most commonly used first generation anti-psychotics, Haloperidol (Haldol). Answer to Poll Question Below (SPOILER) —————————————————— Answer: Choice C (Fluphenazine) --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

Join us as we start off the anti-psychotic series! Today, we will discuss the very first antipsychotic brought to market in the United States, Thorazine (Chlorpromazine). Answer to Poll Question Below (SPOILER) ------------------------------------------------------ Answer: D (Hiccups) --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

Join us and special guest Dr. Jason Cafer, author of Cafer's Psychopharmacology, for a Q&A on antipsychotics and schizophrenia. For more information visit: https://www.cafermed.com/ Answer to poll question below (SPOILER) ————————————————— Answer: Option B: B Vitamins. --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

Join us for the second episode of our Schizophrenia series. Today, we will be discussing the pathophysiology and some of the receptors of interest in this disorder. --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

Welcome to our first episode on Schizophrenia! We will be talking about diagnosis, history, treatment, and much more on this mini-series. --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

On this episode, we will discuss two additional mood stabilizers Carbamazepine (Tegretol) and it's cousin Oxcarbazepine (Trileptal). --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

Welcome to today's episode where we discuss another mood stabilizer, Lamotrigine (Lamictal). --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

Welcome to our next mood stabilizer episode, today we will be discussing Valproic Acid! Other medication names you may encounter: Depakote DR, ER, and Depakene. --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

What is Delirium? Join us for a special guest episode with Dr. Lorrie Garces MD, a consultation liaison psychiatrist. --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

Are you a medical student, resident, psychiatric nurse practitioner, or PA? Join us as we highlight some of our favorite resources for starting psychiatric training. We'll also share tips to help incoming residents.

Join us for a discussion about non-medication based treatments for ADHD.